April 17, 2020

The Food and Drug Administration announced a drug shortage for Tacrolimus, part of the in the Oral Immunosuppressives drug class. In response VDP temporarily removed the non-preferred status from the generic formulations of the NDCs below effective April 17. These changes will allow providers to prescribe for these drugs without requiring a PDL prior authorization and allow continued access to necessary medication for clients. This is a temporary change until the preferred products are sufficiently available in the market. VDP will announce any further PDL status changes of these NDCs.

Contact vdp-formulary@hhsc.state.tx.us for more information.

NDC Label Name
00469060773 PROGRAF 0.5 MG CAPSULE
00469061773 PROGRAF 1 MG CAPSULE
00469065773 PROGRAF 5 MG CAPSULE
00469123050 PROGRAF 0.2 MG GRANULE PACKET
00469133050 PROGRAF 1 MG GRANULE PACKET
Tags: 
PDL